AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 84 filers reported holding AMRYT PHARMA PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,967,628 | +14.0% | 820,825 | -42.9% | 0.92% | +34.9% |
| Q4 2022 | $10,493,443 | +5.5% | 1,437,458 | 0.0% | 0.68% | +5.6% |
| Q3 2022 | $9,947,000 | -8.9% | 1,437,458 | -8.0% | 0.64% | +17.5% |
| Q2 2022 | $10,922,000 | +23.2% | 1,562,458 | +45.8% | 0.55% | +39.8% |
| Q1 2022 | $8,862,000 | – | 1,071,536 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |